← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

FMC Corporation (FMC) 10-Year Financial Performance & Capital Metrics

FMC • • Industrial / General
Basic MaterialsAgricultural InputsCrop Protection & ChemicalsCrop Protection Chemical Manufacturers
AboutFMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. FMC Corporation was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.Show more
  • Revenue $4.25B -5.4%
  • EBITDA $906M -16.8%
  • Net Income $340M -74.2%
  • EPS (Diluted) 2.72 -74.1%
  • Gross Margin 37.15% -12.7%
  • EBITDA Margin 21.33% -12.1%
  • Operating Margin 15.42% -17.4%
  • Net Margin 8% -72.8%
  • ROE 7.6% -77.4%
  • ROIC 6.18% -28.7%
  • Debt/Equity 0.78 -16.3%
  • Interest Coverage 2.78 -21.4%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Excellent 3Y average ROE of 21.3%
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Healthy 5Y average net margin of 15.3%
  • ✓Trading at only 0.4x book value

✗Weaknesses

  • ✗Weak momentum: RS Rating 9 (bottom 9%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.68%
5Y-1.63%
3Y-5.59%
TTM-14.7%

Profit (Net Income) CAGR

10Y1.01%
5Y-6.57%
3Y-22.83%
TTM-136.75%

EPS CAGR

10Y1.74%
5Y-5.45%
3Y-21.9%
TTM-136.56%

ROCE

10Y Avg12.33%
5Y Avg13.49%
3Y Avg11.98%
Latest7.62%

Peer Comparison

Crop Protection Chemical Manufacturers
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
FMCFMC Corporation1.93B15.485.69-5.36%-15.05%-14.07%31.19%0.78
AVDAmerican Vanguard Corporation122.41M4.30-0.96-5.53%-21.15%-50.73%0.72

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+3.28B3.28B2.88B4.29B4.61B4.64B5.05B5.8B4.49B4.25B
Revenue Growth %0.01%0%-0.12%0.49%0.08%0.01%0.09%0.15%-0.23%-0.05%
Cost of Goods Sold+2.16B1.59B1.75B2.37B2.62B2.58B2.86B3.42B2.58B2.67B
COGS % of Revenue0.66%0.48%0.61%0.55%0.57%0.56%0.57%0.59%0.57%0.63%
Gross Profit+1.12B950.6M1.13B1.92B1.99B2.07B2.19B2.39B1.91B1.58B
Gross Margin %0.34%0.29%0.39%0.45%0.43%0.44%0.43%0.41%0.43%0.37%
Gross Profit Growth %-0.04%-0.15%0.18%0.7%0.04%0.04%0.06%0.09%-0.2%-0.17%
Operating Expenses+616.6M573.8M621.7M982.8M1.02B945M1.02B1.1B1.07B922.6M
OpEx % of Revenue0.19%0.17%0.22%0.23%0.22%0.2%0.2%0.19%0.24%0.22%
Selling, General & Admin472.9M439.3M480.2M695.1M717M657.1M715.4M781.7M741.6M644.6M
SG&A % of Revenue0.14%0.13%0.17%0.16%0.16%0.14%0.14%0.13%0.17%0.15%
Research & Development143.7M141.5M141.5M287.7M298.1M287.9M304.7M314.2M328.8M278M
R&D % of Revenue0.04%0.04%0.05%0.07%0.06%0.06%0.06%0.05%0.07%0.07%
Other Operating Expenses0000000000
Operating Income+504.6M376.8M504.6M936.9M976.5M1.12B1.17B1.29B837.9M654.7M
Operating Margin %0.15%0.11%0.18%0.22%0.21%0.24%0.23%0.22%0.19%0.15%
Operating Income Growth %-0.14%-0.25%0.34%0.86%0.04%0.15%0.04%0.11%-0.35%-0.22%
EBITDA+623.1M492.7M614.3M1.09B1.22B1.28B1.33B1.46B1.09B905.7M
EBITDA Margin %0.19%0.15%0.21%0.26%0.26%0.28%0.26%0.25%0.24%0.21%
EBITDA Growth %-0.12%-0.21%0.25%0.78%0.11%0.05%0.04%0.1%-0.25%-0.17%
D&A (Non-Cash Add-back)118.5M115.9M109.7M157.8M241M158.3M160.6M166.4M251.2M251M
EBIT-49.1M244.3M260.8M742.5M814.7M878.4M1.02B1.13B535M486.4M
Net Interest Income+-60.9M-62.9M-79.1M-133.1M-158.5M-151.2M-131.1M-151.8M-237.2M-235.8M
Interest Income1.3M600K900K1.4M1.9M100K0000
Interest Expense62.2M63.5M80M134.5M160.4M151.3M131.1M151.8M237.2M235.8M
Other Income/Expense-635.1M-196M-323.8M-328.5M-321.5M-390.6M-268.7M-307M-537.7M-402.2M
Pretax Income+-130.5M180.8M180.8M608.4M655M729.8M897.8M983.9M300.2M252.5M
Pretax Margin %-0.04%0.06%0.06%0.14%0.14%0.16%0.18%0.17%0.07%0.06%
Income Tax+47.4M50.1M264.1M70.8M111.5M150.9M92.5M145.2M-1.12B-150.9M
Effective Tax Rate %-3.75%1.16%2.96%0.83%0.73%0.76%0.82%0.75%4.39%1.35%
Net Income+489M209.1M535.8M502.1M477.4M552.4M739.6M736.5M1.32B339.9M
Net Margin %0.15%0.06%0.19%0.12%0.1%0.12%0.15%0.13%0.29%0.08%
Net Income Growth %0.59%-0.57%1.56%-0.06%-0.05%0.16%0.34%-0%0.79%-0.74%
Net Income (Continuing)-177.9M130.7M-83.3M537.6M543.5M578.9M805.3M838.7M1.42B403.4M
Discontinued Operations-736.8M0-733.1M00000-98.5M-61.8M
Minority Interest42.6M35.3M25.3M89.3M29.1M22.4M19.4M23M22.5M21.3M
EPS (Diluted)+3.661.563.993.693.604.215.715.8010.512.72
EPS Growth %0.6%-0.57%1.56%-0.08%-0.02%0.17%0.36%0.02%0.81%-0.74%
EPS (Basic)3.661.563.993.743.644.245.755.8310.512.73
Diluted Shares Outstanding133.7M134.5M134.3M135.9M132M130.58M129.15M126.71M125.53M125.2M
Basic Shares Outstanding133.7M133.9M134.25M134.4M130.76M129.7M128.4M125.97M125.53M124.9M
Dividend Payout Ratio0.18%0.42%0.17%0.18%0.44%0.41%0.33%0.36%0.22%0.85%

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+2.97B2.85B3.65B4.03B4.07B4.38B5.05B5.44B5.13B4.96B
Cash & Short-Term Investments78.6M64.2M283M190.8M339.1M568.9M516.8M572M302.4M357.3M
Cash Only78.6M64.2M283M161.7M339.1M568.9M516.8M572M302.4M357.3M
Short-Term Investments00029.1M000000
Accounts Receivable1.87B1.81B2.05B2.36B2.46B2.53B2.81B3.04B2.95B3.17B
Days Sales Outstanding208.33201.6259.52200.93194.81198.77203.28191.47239.58272.11
Inventory800.2M703.5M992.5M1.1B1.02B1.1B1.52B1.65B1.72B1.2B
Days Inventory Outstanding135.51161.67206.74169.31141.78155.2194.32176.5244.13164.34
Other Current Assets241.7M485.4M195M503.4M250.1M172M65M158.6M141.7M221.2M
Total Non-Current Assets+3.35B3.29B5.55B5.94B5.8B5.81B5.62B5.73B6.8B6.7B
Property, Plant & Equipment1.02B1B1.03B1.03B922.7M919M952.2M973.4M1.01B849.7M
Fixed Asset Turnover3.22x3.28x2.81x4.15x5.00x5.05x5.30x5.96x4.42x5.00x
Goodwill776.1M777.5M1.2B1.47B1.47B1.47B1.46B1.59B1.59B1.51B
Intangible Assets837M793.4M2.63B2.77B2.75B2.78B2.67B2.64B2.59B2.36B
Long-Term Investments2.5M1M1.4M700K138.8M134.3M9.2M14.5M19.8M25.6M
Other Non-Current Assets435.1M471.3M443.6M356.8M265.5M275.8M334.8M303.7M244.4M428.2M
Total Assets+6.33B6.14B9.21B9.97B9.87B10.19B10.67B11.17B11.93B11.65B
Asset Turnover0.52x0.53x0.31x0.43x0.47x0.46x0.47x0.52x0.38x0.36x
Asset Growth %0.18%-0.03%0.5%0.08%-0.01%0.03%0.05%0.05%0.07%-0.02%
Total Current Liabilities+1.45B1.44B2.21B2.99B2.72B2.83B3.52B3.8B3.38B3.02B
Accounts Payable403.6M317.4M714.2M795.5M900.1M946.7M1.14B1.25B602.4M768.5M
Days Payables Outstanding68.3572.94148.77122.74125.48134.1144.92133.8285.27105.1
Short-Term Debt112.6M94.2M192.6M547.7M259.2M363.9M440.8M540.8M934M337.4M
Deferred Revenue (Current)1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Liabilities611.1M713.5M724.7M1.01B904.2M997.9M322.2M269.8M1.16B258.9M
Current Ratio2.04x1.98x1.65x1.35x1.50x1.55x1.44x1.43x1.52x1.64x
Quick Ratio1.49x1.49x1.20x0.98x1.12x1.16x1.00x1.00x1.01x1.24x
Cash Conversion Cycle275.49290.33317.49247.49211.11219.86252.69234.16398.44331.34
Total Non-Current Liabilities+2.96B2.71B4.29B3.77B4.59B4.37B4.01B3.97B4.11B4.13B
Long-Term Debt2.04B1.8B2.99B2.18B3.03B2.93B2.73B2.73B3.02B3.03B
Capital Lease Obligations34.3M28M22.5M17.3M163.2M151.1M140M128.6M123.2M106.1M
Deferred Tax Liabilities173.2M167.4M173.2M330.8M333.2M350M342.4M321.5M158.1M86M
Other Non-Current Liabilities720.5M881.3M857.2M915.8M1.06B942.6M784.7M777.4M803.3M899.8M
Total Liabilities4.42B4.15B6.5B6.76B7.31B7.2B7.53B7.77B7.49B7.14B
Total Debt+2.15B1.89B3.19B2.74B3.45B3.44B3.34B3.42B4.11B3.5B
Net Debt2.07B1.83B2.9B2.58B3.11B2.88B2.82B2.85B3.8B3.14B
Debt / Equity1.10x0.93x1.17x0.85x1.35x1.15x1.06x1.01x0.93x0.78x
Debt / EBITDA3.45x3.84x5.19x2.51x2.84x2.69x2.51x2.35x3.77x3.86x
Net Debt / EBITDA3.32x3.71x4.73x2.36x2.56x2.25x2.12x1.96x3.49x3.47x
Interest Coverage8.11x5.93x6.31x6.97x6.09x7.41x8.90x8.50x3.53x2.78x
Total Equity+1.95B2.03B2.73B3.21B2.56B2.98B3.14B3.4B4.43B4.51B
Equity Growth %0.25%0.04%0.35%0.17%-0.2%0.17%0.05%0.08%0.3%0.02%
Book Value per Share14.5915.0820.3523.6219.4022.8524.3426.8435.3236.01
Total Shareholders' Equity1.91B1.99B2.71B3.12B2.53B2.96B3.12B3.38B4.41B4.49B
Common Stock18.6M18.6M18.6M18.6M18.6M18.6M18.6M18.6M18.6M18.6M
Retained Earnings3.38B3.51B3.95B4.33B4.19B4.51B5.09B5.56B6.59B6.64B
Treasury Stock-1.5B-1.51B-1.5B-1.7B-2.09B-2.14B-2.54B-2.65B-2.72B-2.72B
Accumulated OCI-457.3M-478.4M-240.3M-308.9M-412M-282.2M-325.5M-459.6M-406.5M-410.6M
Minority Interest42.6M35.3M25.3M89.3M29.1M22.4M19.4M23M22.5M21.3M

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-357.7M497.8M335.5M368.4M488.5M647.8M820.1M582.4M-386.4M671.1M
Operating CF Margin %-0.11%0.15%0.12%0.09%0.11%0.14%0.16%0.1%-0.09%0.16%
Operating CF Growth %-1.96%2.39%-0.33%0.1%0.33%0.33%0.27%-0.29%-1.66%2.74%
Net Income-177.9M245.4M-83.3M654.9M543.5M578.9M805.3M838.7M1.42B401.7M
Depreciation & Amortization115.7M137.1M113M168.2M150.1M162.7M170.9M169.4M251.2M169.4M
Stock-Based Compensation15.4M20.2M21.1M23M25.6M18.9M17.8M24.2M25.9M23.8M
Deferred Taxes19.9M58.1M104.2M-47.4M46.1M33.6M10.6M-52.7M-1.29B-340.3M
Other Non-Cash Items65.6M-21.3M-35.9M-218.1M-10.9M-19.3M-73.1M-39.1M15.2M182.8M
Working Capital Changes-396.4M58.3M216.4M-212.2M-265.9M-127M-111.4M-358.1M-803.2M233.7M
Change in Receivables140.9M-6.1M-262.4M-302.2M-123.5M-71.8M-241.1M-443.9M192.4M-348.8M
Change in Inventory78.3M72.5M-96.8M-224.2M6.4M-59.7M-320.7M-182.3M-72.8M475.8M
Change in Payables-292.5M-24.1M331.7M182.3M103M61.8M144.4M165.3M-626M171.7M
Cash from Investing+348.8M-155.2M-1.33B-130.9M-186.7M-169.3M-112M-266.4M-154.4M263.6M
Capital Expenditures-108.5M-91.2M-85.7M-156.6M-93.9M-67.2M-100.1M-142.3M-133.9M0
CapEx % of Revenue0.03%0.03%0.03%0.04%0.02%0.01%0.02%0.02%0.03%0.02%
Acquisitions----------
Investments----------
Other Investing-1.29B-45.9M-22.5M-21.4M-44.8M-56.5M6M74.1M-4M-71.6M
Cash from Financing+-16.7M-377M1.21B-363.3M-124.2M-250.3M-747.9M-237.4M331.5M-870.1M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid-86.4M-88.6M-88.8M-89.2M-210.3M-228.5M-247.2M-267.5M-290.5M-290.6M
Share Repurchases----------
Other Financing1.4M-20.3M-11.5M30.9M-134.6M-12.2M-2.4M15.8M-1.4M-700K
Net Change in Cash----------
Free Cash Flow+-466.2M367M249.8M211.8M394.6M580.6M720M440.1M-520.3M603.2M
FCF Margin %-0.14%0.11%0.09%0.05%0.09%0.13%0.14%0.08%-0.12%0.14%
FCF Growth %-4.13%1.79%-0.32%-0.15%0.86%0.47%0.24%-0.39%-2.18%2.16%
FCF per Share-3.492.731.861.562.994.455.583.47-4.144.82
FCF Conversion (FCF/Net Income)-0.73x2.38x0.63x0.73x1.02x1.17x1.11x0.79x-0.29x1.97x
Interest Paid74.7M81.6M98.8M133.4M140.9M141.8M125.8M144M229.6M232.2M
Taxes Paid340.3M62.8M33.3M135.3M130.9M82.1M139.2M122M180.1M156.3M

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)27.82%10.51%22.51%16.9%16.54%19.92%24.14%22.51%33.67%7.6%
Return on Invested Capital (ROIC)10.53%7.17%7.97%12.3%12.77%14.57%14.8%15.85%8.67%6.18%
Gross Margin34.22%28.96%39.13%44.8%43.2%44.49%43.34%41.14%42.53%37.15%
Net Margin14.92%6.37%18.61%11.72%10.36%11.9%14.66%12.69%29.39%8%
Debt / Equity1.10x0.93x1.17x0.85x1.35x1.15x1.06x1.01x0.93x0.78x
Interest Coverage8.11x5.93x6.31x6.97x6.09x7.41x8.90x8.50x3.53x2.78x
FCF Conversion-0.73x2.38x0.63x0.73x1.02x1.17x1.11x0.79x-0.29x1.97x
Revenue Growth0.55%0.18%-12.3%48.87%7.57%0.7%8.68%15.01%-22.67%-5.36%

Revenue by Segment

2015201620172018201920202021202220232024
Insecticides----2.77B2.84B3.02B3.35B2.64B2.38B
Insecticides Growth-----2.28%6.46%10.81%-21.13%-9.91%
Herbicides----1.23B1.19B1.38B1.65B1.28B1.28B
Herbicides Growth------3.39%15.84%20.09%-22.60%0.16%
Fungicides----271.4M275.5M325.5M383.9M317.6M352.5M
Fungicides Growth-----1.51%18.15%17.94%-17.27%10.99%
Plant Health------216.8M234.1M186.9M200.5M
Plant Health Growth-------7.98%-20.16%7.28%
FMC Agricultural Solutions2.25B2.27B2.53B4.29B------
FMC Agricultural Solutions Growth-0.97%11.27%69.30%------
Lithium---442.5M------
Lithium Growth----------
FMC Minerals238.1M264.1M347.4M-------
FMC Minerals Growth-10.92%31.54%-------
FMC Health and Nutrition785.5M743.5M--------
FMC Health and Nutrition Growth--5.35%--------

Revenue by Geography

2015201620172018201920202021202220232024
Latin America981.8M821.4M868.6M1.21B1.44B1.46B1.63B2.09B1.4B1.39B
Latin America Growth--16.34%5.75%39.55%18.94%1.03%12.15%27.84%-32.90%-0.83%
North America911.1M879.1M708.1M1.18B1.12B1.03B1.12B1.44B1.2B1.17B
North America Growth--3.51%-19.45%65.97%-4.60%-7.90%8.20%28.52%-16.09%-2.61%
Asia Pacific759.7M798.5M718.5M1.3B1.05B1.11B1.25B1.24B981.7M848.4M
Asia Pacific Growth-5.11%-10.02%80.93%-19.60%5.89%13.35%-1.28%-20.74%-13.58%
EMEA623.9M783.4M583.4M1.04B1B1.05B1.04B1.04B899.2M834.8M
EMEA Growth-25.56%-25.53%78.35%-3.72%4.44%-0.60%-0.03%-13.51%-7.16%

Frequently Asked Questions

Valuation & Price

FMC Corporation (FMC) has a price-to-earnings (P/E) ratio of 5.7x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

FMC Corporation (FMC) reported $3.56B in revenue for fiscal year 2024. This represents a 5% increase from $3.38B in 2011.

FMC Corporation (FMC) saw revenue decline by 5.4% over the past year.

FMC Corporation (FMC) reported a net loss of $534.9M for fiscal year 2024.

Dividend & Returns

Yes, FMC Corporation (FMC) pays a dividend with a yield of 14.99%. This makes it attractive for income-focused investors.

FMC Corporation (FMC) has a return on equity (ROE) of 7.6%. This is below average, suggesting room for improvement.

FMC Corporation (FMC) had negative free cash flow of $409.4M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.